WBCPJ:AU:AU-Westpac Banking Corporation (AUD)

CAPITAL NOTES | |

Last Closing

USD 105.8

Change

-0.25 (-0.24)%

Market Cap

USD 83.23B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-14 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
CBAPI:AU Commonwealth Bank of Australia..

N/A

USD 191.08B
CBAPG:AU Commonwealth Bank of Australia..

N/A

USD 177.78B
CGFPC:AU Challenger Ltd Preferred

N/A

USD 4.44B
MGF:AU Magellan Global Fund Unit

N/A

USD 2.85B
LSF:AU L1 Long Short Fund Ltd

+0.01 (+0.32%)

USD 1.90B
ASK:AU ABACUS STORAGE KING

N/A

USD 1.59B
VG1:AU VGI Partners Global Investment..

+0.01 (+0.26%)

USD 0.77B
KKC:AU Kkr Credit Income Fund

-0.02 (-0.86%)

USD 0.73B
RF1:AU Regal Investment Fund

-0.08 (-2.42%)

USD 0.54B
PCI:AU Perpetual Credit Income Trust

-0.01 (-0.45%)

USD 0.43B

ETFs Containing WBCPJ:AU

SUBD:AU VanEck Australian Subordi.. 5.49 % 0.00 %

N/A

USD 1.38B
GERM ETFMG Treatments Testing .. 5.30 % 0.00 %

-0.15 (0.17%)

USD 0.01B
US3:PA 4.97 % 0.00 %

N/A

N/A
PTH Invesco DWA Healthcare Mo.. 2.66 % 0.60 %

-0.22 (0.17%)

USD 0.14B
US1:PA 2.18 % 0.00 %

N/A

N/A
CNCR Loncar Cancer Immunothera.. 1.88 % 0.79 %

-0.21 (0.17%)

USD 0.02B
FLOT:AU VanEck Australian Floatin.. 1.82 % 0.00 %

N/A

USD 0.69B
UEFZ:F UBS ETF SICAV - SBI Forei.. 1.53 % 0.00 %

+0.01 (+0.17%)

USD 0.40B
UEFZ:XETRA UBS - SBI Foreign AAA-BBB.. 1.53 % 0.00 %

+0.02 (+0.17%)

USD 0.42B
F5ESG:SW UBS(Lux)Fund Solutions .. 1.53 % 0.00 %

+0.02 (+0.17%)

USD 0.40B
FYC First Trust Small Cap Gro.. 0.82 % 0.70 %

-0.14 (0.17%)

USD 0.27B
FYX First Trust Small Cap Cor.. 0.41 % 0.63 %

-0.46 (0.17%)

USD 0.86B
XCCC BondBloxx ETF Trust 0.05 % 0.00 %

-0.18 (0.17%)

USD 0.06B

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.07% N/A N/A 58% F
Dividend Return 1.31% N/A N/A 31% F
Total Return 3.38% N/A N/A 59% D-
Trailing 12 Months  
Capital Gain 2.52% N/A N/A 61% D-
Dividend Return 5.12% N/A N/A 66% D+
Total Return 7.64% N/A N/A 64% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.08% N/A N/A 43% F
Dividend Return 2.00% N/A N/A 44% F
Total Return 2.09% N/A N/A 41% F
Risk Return Profile  
Volatility (Standard Deviation) 2.56% N/A N/A 99% N/A
Risk Adjusted Return 78.15% N/A N/A 95% A
Market Capitalization 83.23B N/A N/A 99% N/A

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.